Non-viral transfection technologies for next-generation therapeutic T cell engineering

This publication has 255 references indexed in Scilit:

• Nanowire-Mediated Delivery Enables Functional Interrogation of Primary Immune Cells: Application to the Analysis of Chronic Lymphocytic Leukemia
  Nano Letters, 2012
• Replication-Competent Retroviruses in Gene-Modified T Cells Used in Clinical Trials: Is It Time to Revise the Testing Requirements?
  Molecular Therapy, 2012
• Transfection optimization for primary human CD8+ cells
  Journal of Immunological Methods, 2011
• Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
  New England Journal of Medicine, 2011
• Distribution of Lentiviral Vector Integration Sites in Mice Following Therapeutic Gene Transfer to Treat β-thalassemia
  Molecular Therapy, 2011
• Adoptively transferred effector cells derived from naïve rather than central memory CD8⁺T cells mediate superior antitumor immunity
  Proceedings of the National Academy of Sciences, 2009
• Efficient siRNA delivery into primary cells by a peptide transduction domain–dsRNA binding domain fusion protein
  Nature Biotechnology, 2009
• Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
  Nature Medicine, 2008
• Adoptive cell transfer: a clinical path to effective cancer immunotherapy
  Nature Reviews Cancer, 2008
• Innate and adaptive immune response to apoptotic cells
  Journal of Autoimmunity, 2007